Bloomage BioTechnology (SHSE:688363) EBIT per Share : ¥1.11 (TTM As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bloomage BioTechnology EBIT per Share?

Bloomage BioTechnology's EBIT per Share for the three months ended in Sep. 2024 was ¥0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.11.

During the past 12 months, the average EBIT per Share Growth Rate of Bloomage BioTechnology was -30.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was -1.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was -13.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 19.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Bloomage BioTechnology's EBIT per Share or its related term are showing as below:

SHSE:688363' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -30.1 Med: 12.7 Max: 36.2
Current: -1.2

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Bloomage BioTechnology was 36.20% per year. The lowest was -30.10% per year. And the median was 12.70% per year.

SHSE:688363's 3-Year EBIT Growth Rate is ranked worse than
56.56% of 1273 companies
in the Chemicals industry
Industry Median: 3.1 vs SHSE:688363: -1.20

Bloomage BioTechnology's EBIT for the three months ended in Sep. 2024 was ¥17 Mil.

Bloomage BioTechnology EBIT per Share Historical Data

The historical data trend for Bloomage BioTechnology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomage BioTechnology EBIT per Share Chart

Bloomage BioTechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

1.61

1.59

1.87

2.38

1.48

Bloomage BioTechnology Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.20	0.20	0.63	0.25	0.04

Bloomage BioTechnology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Bloomage BioTechnology's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	712.458	/	481.753
=	1.48

Bloomage BioTechnology's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	17.306	/	485.376
=	0.04

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.11

Bloomage BioTechnology (SHSE:688363) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Bloomage BioTechnology EBIT per Share Related Terms

Thank you for viewing the detailed overview of Bloomage BioTechnology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bloomage BioTechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bloomage BioTechnology Corp Ltd (SHSE:688363) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 678 Tianchen Avenue, High-Tech Development Zone, Shandong Province, Jinan City, CHN

Website

http://www.bloomagebio-tech.com

Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.

Executives

Zhao Yi	Core technical personnel
Luan Yi Hong	Core technical personnel
Shi Yan Li	Core technical personnel
Liu Jian Jian	Core technical personnel
Wang Yu Ling	Core technical personnel
Zhou Wei	Core technical personnel
Huang Si Ling	Core technical personnel
Han Hong Ling	Core technical personnel
Lu Zhen	Core technical personnel

Bloomage BioTechnology Headlines

No Headlines